Idexx Laboratories has launched a total T4 dry-slide test, giving veterinary surgeons real-time access to additional chemistry information.
The new test is compatible with all the company’s in-clinic laboratory analysers.
Simon Wootton, UK Marketing Manager from Idexx says that it is important for vets to be able to update a patient’s chemistry during a visit: “Conditions like hyper- or hypothyroidism require intervention and careful long-term monitoring. It is also important to assess the possible effects on other relevant medical parameters. This is why vets often want to update a patient’s chemistry data during the clinic visit. To accommodate this need, accurate and dependable chemistry, electrolyte and T4 test results can now be delivered in as little as 15 minutes.
“By adding thyroid screening to diagnostic protocols – which may already include fructosamine, phenobarbital, and urine P:C testing – practices can now get comprehensive chemistry, electrolyte and T4 measurements from a single sample, in a single run. This will let vets detect abnormalities sooner and respond more effectively.”
For more information, visit: https://www.idexx.com
The equine events will initially take place at Rossdales Equine Hospital in Suffolk on 22nd October and at Ashbrook Veterinary Hospital in Cheshire on 5th December.
The roadshow will see a range of speakers renowned in the fields of equine veterinary medicine and QI share practical examples of improving outcomes for equine patients. Interactive workshops, real-life scenarios and case studies will show how QI techniques can be applied in practice to help teams prevent and respond to errors.
Confirmed speakers include Professor Debra Archer, Head of Equine Surgery and Professor in Equine Surgery at the University of Liverpool, Dr Alice Bird, Senior Clinical Anaesthetist at the Animal Health Trust and Dr Rachel Dean, Director of Clinical Research and Excellence in Practice, VetPartners.
President Elect of BEVA, Tim Mair, said: "There are many challenges to being an equine vet and running a successful equine practice. Even in large practices and equine hospitals, there is a risk that we operate in our own little bubble and assume that what we are doing is best practice, whereas in reality we could often do a better job.
"Clinical governance and quality improvement are tools that allow us to critically appraise our day-to-day work and identify ways in which we can continuously improve what we do – to the benefit of our patients and clients, as well as to ourselves."
The canine hip dysplasia roadshow will begin on 9th October in Gatwick, Surrey.
The event will review the condition prevalent in dogs, how best to investigate it and the available treatment options. Case examples will be used to show how the evidence can be evaluated, explain how to measure treatment outcomes and show how the use of checklists can help minimise potential errors.
It will be hosted by Mark Morton, RCVS Specialist in Small Animal Surgery (Orthopaedics). He said: "As vets we probably all undertake bits of QI on a day-to-day basis (whether we realise it or not!) but there is so much more we can do to embed it into our clinical work. Checklists, treatment guidelines and clinical auditing significantly improve our patient care and our outcomes.
"Whilst looking at hip dysplasia and the treatment options in detail, hopefully this roadshow will show how we can apply these ideas to improve our management of this condition as well as using them elsewhere.”
For the full programme of each event and to buy tickets, visit bit.ly/RCVSKnowledgeEvents.
Anyone interested in booking an RCVS Knowledge roadshow for their region can do so by contacting ebvm@rcvsknowledge.org.
The rationale for completing a course of antibiotics has always been to prevent the growth of drug-resistant bacteria. However, the article says there is little evidence to support this idea, and that in fact, taking antibiotics for longer than necessary presents a greater risk of causing antibiotic resistance.
Responding to article, BVA Junior Vice President John Fishwick said: "We're very aware of the global threat antimicrobial resistance poses to human and animal health, and the UK veterinary profession is committed to the responsible use of antibiotics. Medicines should never be used to compensate for poor husbandry practices and routine habitual prophylactic use in healthy animals to prevent disease is a no-go.
"The article in the BMJ suggests that antibiotics should be used for as short a period as possible, and that we should move away from the concept of following a predetermined course. This may indeed be a very important advance, but it is far too early to determine how this would work in veterinary practice. We need to clearly establish the evidence supporting it.
"We support the researchers’ calls for clinical trials to determine the most effective strategies for antibiotic treatment. Until further studies are conducted, it is too early to change the way we prescribe medicines and vets should continue to prescribe as previously, only when necessary. It is also vital that clients continue to follow the directions given by their vets, both in terms of dosage and duration of treatment, carefully."
The course counts for four hours CPD, split into six short sessions which can be completed in your own time.
Presented by Dr Dan Cripwell BSc (Hons) BVSc CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox, the sessions consist of:
There is a quiz at the end of each module, following which, you can download a CPD certificate.
Suzy Ramsay, head of sales and marketing at Jurox (UK) Limited, said: “We are committed to developing unique and world class anaesthesia and analgesic products and practices within the animal health industry through the provision of up-to-date technical support and education. Our new Jurox Anaesthesia Academy CPD platform will enable veterinary professionals to adopt an evidence-based approach to their anaesthetic product choice and, in turn, help achieve the best possible anaesthetic outcomes for their patients.”
For access to the Jurox Anaesthesia Academy CPD platform, visit https://cpd.jurox.co.uk.
For further information, contact your local Jurox account manager, phone 0800 500 3171 or email customerservice@jurox.co.uk.
Pfizer has divested itself of its animal health business unit, which has become a stand-alone company called Zoetis. The new company unveiled its vision for Europe, Africa and the Middle East (EuAfME) region at a press conference in Paris last week.
The company says it aims to have its products, services and people as the most valued by animal health customers around the region, and the world.
Alejandro Bernal, Zoetis Executive Vice President and Area President for the EuAfME region said: "We are united around this shared vision, and we strive every day to help customers meet their real-world challenges through quality medicines and vaccines, complemented by diagnostic products, genetic tests and a range of services," said "As the largest standalone company in the industry, we are dedicated solely to animal health and focusing on our core business so our customers can grow theirs."
In addition to working closely with customers, Zoetis said it strives to collaborate with universities and other research organisations, to help advance the animal health sector and those who raise and care for animals. One example of this is the partnership with the University of Stirling, one of the leading research organisations, based in Scotland.
Professor Randolph Richards, from Stirling said: "Academia is increasingly realising the benefits of working with industry on research projects, and is concentrating on those with more direct impact rather than on pure research. In our own case, Zoetis has been able to provide resources which were otherwise unavailable to us, with funding opportunity being provided through the UK Technology Strategy Board."
The programme for the day includes a talk by Matt Rendle, an exotics veterinary nurse, about wound healing in reptiles and the work of the Veterinary Wound Library.
There are also talks about current veterinary practice concerning Chelonia (with a focus on egg retention), the Asian turtle crisis, zoo conservation work, reptile rescue work and perceptions of Chelonia in captivity.
Tickets cost £30-£50, and include refreshments, lunch and optional Sunday workshops.
For more details or to reserve your place, email: turtlesurvivaleurope@gmail.com, or visit: https://www.turtlesurvival.eu/
Vetswest, the veterinary support services company, has been acquired by MWI Veterinary Supply, a subsidiary of the US multinational, AmerisourceBergen.
MWI already owns Centaur and VetSpace, and the agreement will allow it to further expand the range of services it offers the animal health profession in the UK.
Jim Cleary, Executive Vice President of AmerisourceBergen and President of MWI Veterinary Supply said: “This partnership reflects our commitment to the success of veterinary practices across the globe. We’re proud to welcome Vetswest to the MWI family as we continue to expand our services in our mission to be the best resource to the animal health profession.”
Vetswest offers group business support services for its 235 member veterinary practices including negotiating manufacturer terms and a proprietary IT system that supports pricing intelligence, inventory information and reporting on purchasing activity. The company also provides access to ancillary services for veterinary surgeons to help manage human resources, continuing professional development, insurance offerings, pension services and other areas which support the growth of member practices.
Vetswest's retiring managing director David Buckley said: “The resources of MWI and AmerisourceBergen will allow us to bring new innovation to the market and additional benefits to Vetswest members. I’m excited about Vetswest’s future under the leadership of Chris Sobey and as part of the MWI and AmerisourceBergen family.”
Chris Sobey, who will become the new managing director of Vetswest following his tenure as Vetswest’s business development director said: “Our goal has always been to improve efficiencies and services for our members through scale and with our new relationship with MWI and AmerisourceBergen, we will be well positioned to further this core mission of our organisation.’’
Norbrook has announced the re-launch of its range of intramammary tubes for lactating and dry cows, to promote holistic herd health and responsible use of antimicrobials.
The company’s range, which includes products across a number of antibiotic classes, primarily targets clinical cases of mastitis in lactating cows, and removal or prevention of infection around the dry period.
Chris Geddes MRCVS, Marketing Manager at Norbrook, says the re-launch is focused on modernising the range and making it clearer for practice staff and farmers to avoid confusion between lactating cow and dry cow products: “We have a wide range of 11 products containing a variety of antimicrobials: for example Duofast is the only lactating cow product to contain trimethoprim and sulfadiazine. We are working with vets to promote responsible use by farmers, for example through the use of our teat sealant Noroseal for Selective Dry Cow Therapy."
The full range includes Duofast, Lactaclox, Cefimam LC, Combiclav, Noroclav and Multiject for the lactating cow; Cefimam DC, Noroclox, Bovaclox and Bovaclox DC Xtra for the dry cow; and teat sealant Noroseal.
Norbrook has also produced a best practice guide to mastitis control, available for vets in English and Polish, which can be shared with farmers.
Chris added: "We recognise the need to reduce overall use of antimicrobials, especially for disease prevention – as well as using non-antimicrobial products such as teat sealants. These practices, together with the recent focus on using older classes of antimicrobials, mean that as an industry we need to adopt a holistic and targeted approach to herd health management.
"We believe that by providing additional information to aid with prevention of disease, and re-launching our intramammary range to make it clearer when products should be used, we can help to achieve that."
Norbrook says the full range of products is in stock, but some wholesalers may hold components of the old range as the new range is phased in.
Earlier this year, the RCVS Council approved the roll-out of a more outcomes-based model of CPD to encourage veterinary professionals to engage in greater reflection on learning and development, and the impact that it has on their professional practice.
To support this approach, Council also approved the development of a new CPD recording platform designed to be more intuitive and to make it easy to record CPD in real time.
The College says the new platform – which has the working title of 'One CPD' – will be a ‘one stop shop’ CPD management solution for veterinary surgeons and nurses at all stages of their careers, including veterinary students and student veterinary nurses.
Richard Burley, RCVS Chief Technology Officer, said: "We’re excited to open up access to this powerful, next-generation, tool we’ve been building and welcome our members into an important phase of the development process. Testing with our members will be absolutely critical in delivering the very best experience possible for all those that use 'One CPD' in the future. Ease of use and truly valuable functionality are key deliverables for us and both these need the feedback of our members to perfect."
Dr Linda Prescott-Clements, RCVS Director of Education (pictured right), added: "The first stage of the development of the CPD recording platform is due to finish in October and so we are looking for a cohort of both veterinary surgeons and nurses who can spend a few months this autumn using the new platform to record and reflect on their CPD, in order to test out some of the new features which aim to make this process so much easier to do. We will consider their feedback carefully in order to improve the recording platform ready for launch in January 2020.
"The new ‘One CPD’ platform will ultimately replace the current Professional Development Record, and its use will become mandatory for recording CPD from January 2022.
"In addition to setting up the testing group, we are also looking to meet with key CPD providers for veterinary surgeons and veterinary nurses over the coming months to discuss our plans for outcomes-based CPD and the development of the recording platform in greater detail."
Veterinary surgeons who'd like to take part in the testing for the CPD app, as well as CPD providers who want to discuss the College’s CPD policy plans, should contact Jenny Soreskog-Turp, RCVS CPD Officer, on cpd@rcvs.org.uk or 020 7202 0701.
Vetoquinol is launching Forcyl, an injectable anti-infective for the targeted therapeutic treatment of respiratory infections in cattle, in November.
Forcyl is a patented 16% marbofloxacin solution, registered as a single intramuscular injection, which the company says will ensure a high level of compliance.
Forcyl follows the SISAAB concept (single injection short acting antibiotic), with an optimised dosage to minimise the risk of development of antibiotic resistance. Shorter exposure time limits the opportunity for resistance to develop. The formulation means a lower volume of administration (10 ml for 160 kg body weight) is required. Vetoquinol says that other benefits of Forcyl include excellent injection site tolerance and short withdrawal periods (meat: 5 days, milk: 48 hours).
For further information on implementing the SISAAB concept in your practice, please contact one of Vetoquinol's large animal team on 01280 814500.
iRecall Consent Management falls into two parts: an initial three staged campaign to gain clients' consent before the 25th May deadline, then ongoing maintenance of the database, managing existing clients' communication preferences and gaining consent for new clients.
Thereafter, iRecall will cross reference consent and communication preferences for any iRecall-powered outbound marketing communication for a practice.
Practice-branded client consent requests are created in real time using live practice data and are personalised for each individual client and their pets.
Consent Management uses the company's SMARTdelivery technology to maximise response rates: first selecting the best delivery method (SMS, email or letter) for each client, based on current information in the practice management system. If a message fails to send because of an invalid number or email address, Consent Management automatically selects the next delivery method.
iRecall says Consent Management already interfaces with the six leading practice management systems, and can interface with any system on request.
Jamie Crittall, Director of Virtual Recall and himself a practice owner said: "Practices need to stop thinking that GDPR is a burden but see it as opportunity to forge stronger relationships with their clients and helping them to keep their pets healthy. Practices who treat their clients’ personal data with the same care that they show their pets will be rewarded with greater trust and loyalty, ensuring the future success of their business. Furthermore, it’s the perfect opportunity for practices to re-engage with previously lapsed clients to make them active and loyal once more - a massive value add."
For more information, visit: http://www.virtualrecall.com/
Mr Wood faced three charges, all relating to allegations of misconduct over a laboratory test for an alpaca while he was working at a practice in South Oxfordshire.
The charges alleged that in September 2023, Mr Wood told the alpaca’s owner that it had tested positive for Johne’s disease when in fact, the animal had not been tested.
He then allegedly sent a letter confirming a positive test result for the test that had not taken place, and then created a false test result report in the name of a veterinary surgeon colleague and sent it to another colleague by email.
He later told the alpaca's owner that he had given her the wrong result by mistake and that the test result was actually negative.
Then in October 2023, he emailed the laboratory saying that a member of his practice’s administrative staff had written the false report.
In November he told the managing partner of his then employer on three occasions that he was investigating the false report in order to find out who sent it.
Finally, he sent a misleading and dishonest email to a veterinary surgeon colleague falsely indicating that a member of the practice’s staff had manufactured the false report, when that was not the case.
At the outset of the hearing Mr Wood admitted the facts of all the allegations against him.
Having found the facts proven, the Committee found that the charges amounted to serious professional misconduct, something which Mr Wood himself also admitted.
The Committee identified a number of aggravating factors in Mr Woods' conduct, including his lack of honesty, probity and integrity, the fact the conduct was premeditated, that it involved a breach of the client’s trust, the abuse of his professional position, the fact the conduct was sustained and repeated over a period of time, and that his conduct contravened advice given by the RCVS.
The mitigating factors included positive testimonials from professional former colleagues and client farmers, the fact that he had engaged in some remediation in order to avoid repeating the dishonest behaviour, and that he showed significant insight into his misconduct.
Dr Neil Slater MRCVS, chairing the Committee and speaking on its behalf, said: “The Committee recognised that the serious repeated dishonesty, which was to conceal wrongdoing, made the respondent’s misconduct particularly serious.
“It therefore gave consideration as to whether his conduct was fundamentally incompatible with being a veterinary surgeon and whether removal was the only appropriate and proportionate sanction in this case.
“The Committee considered that this was a particularly difficult case to reconcile, as, on the one hand the misconduct was so serious whereas on the other hand, the respondent had demonstrated significant insight; the risk of repetition was low; the evidence of his professional achievements was strong and the testimonials from client farmers and professional colleagues were impressive.”
He added: “The Committee considers that suspension is sufficient in the circumstances of this case to satisfy public confidence in the profession and to uphold proper professional standards of conduct and behaviour.
"The Committee therefore imposes a suspension of 18 months on the respondent.
"In determining this length, the Committee considered that this was the least period necessary in order to meet the significant public interest considerations in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Virbac has launched Deltanil, a deltamethrin-based pour-on solution indicated in dairy and beef cattle for use against flies and lice with a zero milk withdrawal period. It is also effective in sheep against ticks, lice, keds and blowfly strike and against lice and ticks in lambs.
Deltanil is presented for use with the company's Farmpack and Flexibag dispensing system, which was awarded the 2014 PharmaPack Award for Innovative Packaging. Virbac says the system offers farmers a convenient approach to treatment, combining easy application with freedom of movement and the flexibility of a long stability period once the product is opened.
The Farmpack backpack holds a 2.5 litre Flexibag of Deltanil solution, sufficient for the treatment of 250 cattle.
The Flexibag is a flexible, multi-layered, multi-component bag designed to protect and preserve medication, giving Deltanil a two year proven stability period after opening. Unopened, Deltanil has a three year shelf life.
Virbac Product Manager for Large Animals Brigitte Goasduf MRCVS said: "External parasites are a year-round threat to dairy and beef herds and can have a significant economic impact on yields. With the launch of Deltanil, we are offering a new approach to product application, one which is ideally suited to the practical conditions on farm and which addresses the challenges often faced in using pour ons.
"We believe that Deltanil, with its zero milk withdrawal period for dairy cattle and sheep and innovative Farmpack and Flexibag dispensing system, sets a new standard for products of this type.
"Deltanil is based on deltamethrin, a tried and trusted parasiticide. It offers a convenient approach to administration with a 10ml dosage per cow, irrespective of weight, and is presented in two sizes - the 2.5 litre Flexibag and a 1litre dispensing bottle. The 1litre bottle offers a year's stability once opened. The dosage per sheep is 5ml, irrespective of weight, with a 2.5ml dosage for lambs."
Samantha, who was a recipient of the Malaysian Prime Minister’s Scholarship, has a degree in genetics, molecular biology and microbiology, and a PhD in cancer research from University College London.
She was diagnosed with ADHD at the age of 40, which led her to set up ADHD Girls, an organisation that helps people with ADHD access employment and works with businesses to help them understand ADHD.
Samantha's talk is part of a module on neurodiversity, which will open with an exploration of neurodiversity and the challenges of diagnosis, before looking at how you can better support those in practice teams, as well as neurodivergent clients and students.
The session will wrap up with a discussion about how to cultivate greater inclusivity and understanding around those who are neurodivergent within the veterinary professions.
Being neurodivergent means that your brain works differently from the average person, meaning there may be differences in social preference, ways of communicating, ways of learning and ways of perceiving the environment.
Samantha said: “No two brains are the same. But what if you were born with a brain that constantly makes you feel like everything you do differentiates you from everyone else?”
“My talk introduces neurodiversity in the context of society, casting light on ADHD and autism, and how this impacts the workplace and one’s quality of life, and what we can do to build a compassionate culture, starting with the conversations we have at work.
"I’m really excited to talk at the BSAVA Congress and meet other professionals in the veterinary field.”
After her lecture, she will be partaking in a panel discussion around the challenges of diagnosis of neurodivergence alongside Laura Playforth, a vet who has been diagnosed with both bipolar and autism and is currently Group Quality Improvement Director at IVC Evidensia.
Andy Green, Vice Chair of the BSAVA Congress Programme Committee chair said: “We are delighted to have Samantha delivering our keynote this year on such an important topic.
"Neurodiversity is becoming an increasingly important area of focus and understanding across society and we have a significant population of neurodivergent people working as vets, nurses and in other roles, many of whom may not as yet have a diagnosis.”
“We also need to recognise that many pet owners and clients are neurodivergent.
"Samantha is ideally placed to shine a spotlight on this subject, using her own story and life experience to deliver a greater understanding of what it actually means to be neurodivergent and how businesses/practices can understand, embrace and support neurodivergent members of the work force and community.”
Early bird tickets for BSAVA Congress 2023 are currently on sale with 3-day and 1-day tickets available to purchase. Get your ticket now: https://www.bsavaevents.com/bsavacongress2023/en/page/home.
The study analysed information from a random sample of 29,865 dogs that died over a one-year period, taken from a study population of 905,544 dogs from 626 clinics in the VetCompass database.
From the sample, 26,676 (91.5%) of deaths recorded in practice involved euthanasia and 2,487 (8.5%) of deaths were unassisted. However, it is unknown how many dogs die unassisted and unreported to a practice.
Perhaps unsurprisingly, the findings indicated that certain types of diseases and conditions were more likely to lead to death by euthanasia than unassisted death.
by contrast,
Larger bodyweights, increasing age and certain breeds of dog were also additional risk factors for euthanasia. Rottweilers were more likely to die by euthanasia compared to Labrador Retrievers as the standard baseline breed. In contrast, breeds such as Bulldogs, Pugs and West Highland White Terriers were more likely to have unassisted deaths, and these deaths were more likely caused by traumatic injury, foreign body and heart disease.
Additional findings from the study included:
Camilla Pegram, VetCompass Epidemiologist at the RVC, and author of the paper, said: “End-of-life discussions between veterinarians and owners can be particularly difficult for both parties. This study provides benchmark data for the relative proportion of deaths that involve euthanasia and for the relative impact from demographics and disorders on euthanasia decision-making. Owners and veterinary professionals may find it easier to discuss end-of-life options, to reach a final decision and be comfortable with these decisions based on a feeling of broader support from the reported actions of others in similar situations.”
Dr Dan O’Neill, Senior Lecturer, Companion Animal Epidemiology, at the RVC, and co-author of the paper, said: "The decision for many animal owners to put a beloved dog to sleep is often the hardest decision of their life. The moment of euthanasia often lives with owners forever. Hopefully, the information from this study can at least help some owners come to terms with the responsibility of helping their dog go with dignity. Understanding that over 90% of other owners also opted for euthanasia may help anyone struggling to make this final and hardest decision.”
Dr Carol Gray, Research Associate at the University of Liverpool and co-author of the paper, said: "Decision-making around euthanasia is shared between veterinarian and owner, although it is the owner who must give consent for euthanasia. Providing this final authorisation is potentially a burden for owners. This paper will help to ease that burden by allowing veterinarians to provide reassurance that they are not the only dog owners to make a decision for euthanasia in similar circumstances.”
Reference
Pegram, C., Gray, C., Packer, R.M.A. et al. Proportion and risk factors for death by euthanasia in dogs in the UK. Sci Rep 11, 9145 (2021). https://doi.org/10.1038/s41598-021-88342-0
The website now contains a range of information on Alfaxan including user experiences, sections on best practice anaesthesia, webinars and details of Jurox’s anaesthesia roadshows.
The webinars include a presentation which explains how to use Alfaxan to achieve the best anaesthetic experience for the patient. There is also series of short online webinars on rabbit anaesthesia:
An online CPD certificate will be issued to veterinary professionals who have viewed each webinar, after they have taken a short online questionnaire.
The Alfaxan website also offers downloadable resources such as the new Considerations for Anaesthetising Rabbits expert panel guidelines booklet, AVA Anaesthetic Safety Checklist Implemenation manual, AVA Anaesthetic Safety Checklist and Alfaxan resource guides, user guides, dose charts and monitoring charts.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Our new Alfaxan website is an educational hub that enables veterinary professionals to learn more about best practice anaesthesia and how this can be implemented in their own clinics. With Alfaxan’s new pet rabbit indication we have included an emphasis on rabbit anaesthesia and how this differs from anaesthesia in cats and dogs."
For further information, visit www.alfaxan.co.uk, contact your local Jurox technical sales representative, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
João, who graduated from Portugal’s Oporto University in 2009, was recruited from the University of Liverpool, where he was a lecturer in Small Animal Cardiology.
Willows Clinical Director Toby Gemmill said: "This is an exciting time for us. As part of our new extension, our state-of-the-art cardiology suite is now open and fully operational, while we have also appointed a hugely knowledgeable and experienced cardiologist to join the team.
"It is further evidence of our continued commitment to invest in top talent and the best facilities so we can provide the highest standards of care and treatment."
João said: "I’m very pleased to have joined a centre of excellence like Willows and to be working in the fantastic new cardiology suite.
"I enjoy all aspects of medical and interventional cardiology but I have a particular interest in feline cardiomyopathies, cardiorenal syndrome and atrial fibrillation."
The Disciplinary Committee considered a number of charges against Javier Salas Navarro MRCVS and Roman Kristin over 35 days.
The charges against Dr Navarro concerned his treatment of a kitten named Marnie. They included:
In August 2016, failing to read the anaesthesia consent form in relation to a surgical spay he performed;
When Marnie was readmitted for surgery, failing to read the anaesthesia consent form, failing to undertake adequate assessment of Marnie’s condition; performing surgery without adequately considering her condition; subjecting Marnie to anaesthesia without recognising the seriousness of her illness; failing to obtain informed consent from the owners; administering medication which was contra-indicated; and failure to make an adequate record of his involvement in Marnie’s care.
The charges against Dr Kristin also related to his treatment of Marnie. They included:
In August 2016, failing to undertake an adequate assessment of her condition; failure to recognise and record the fact that Marnie could not pass urine; failure to refer or offer her for specialist treatment; and failure to ensure Marnie received care and treatment overnight.
When admitting Marnie for surgery, that he made a number of clinical mistakes including failure to gain informed consent; and failure to recognise the seriousness of her illness;
that there were a number of failings in relation to Marnie’s care, including failure to arrange adequate overnight care, failure to monitor and record her condition, and failure to gain informed consent for the overnight care.
that he failed to advise Marnie’s owners that he suspected her uterers had been ligated during the spay, failed to advise Marnie’s owners that she required specialist veterinary treatment; and advised that Marnie undergo further surgery at the practice in spite of this meaning her having to undergo further anaesthesia in a week and with poor chances of survival;
that the above conduct was misleading and dishonest.
The Disciplinary Committee found a number of the facts in the charges against both Dr Navarro and Dr Kristin proven (the full details can be found in the documentation at www.rcvs.org.uk/disciplinary).
The Committee found that Dr Navarro breached a number of aspects of the Code of Professional Conduct for Veterinary Surgeons including: making animal health and welfare the first consideration when attending to animals; the provision of appropriate and adequate veterinary care; responsible prescription, supply and administration of medicines; communication with professional colleagues to ensure the health and welfare of the animal; being open and honest with clients and respecting their needs and requirements; effective communication with clients; keeping clear and accurate clinical records; and working with the veterinary team to coordinate the care of animals.
Of the proven charges, the Committee found that his initial failure to read Marnie’s anaesthesia consent form on 5 August did not amount to disgraceful conduct in a professional respect, but that the repetition of this failure on 9 August did amount to disgraceful conduct. It also found that Dr Navarro’s failure to undertake adequate assessment and perform surgery without this assessment amounted to serious professional misconduct. Furthermore, the Committee found that subjecting Marnie to anaesthesia in spite of her being unwell, failure to obtain informed consent and failure to keep adequate records also amounted to serious professional misconduct.
For Dr Kristin, in summary, the Committee found not proven the allegation that he had failed to respond on 5 August 2016 to concerns from Marnie’s owners about her condition while she was recovering from a surgical spay and also all the allegations relating to Dr Kristin’s admission of Marnie to the practice on 9 August on the basis that it was not satisfied so as to be sure that Dr Kristin had been the veterinary surgeon who admitted Marnie on that day.
The Committee found proven the remaining charges and found he breached the following parts of the Code of Professional Conduct for Veterinary Surgeons: making animal health and welfare the first consideration when attending to animals; keeping within area of competence and referring responsibly; providing appropriate and adequate veterinary care; responsible prescribing, supply and administration of medicines; communication with colleagues to ensure the health and welfare of the animal; being open and honest with clients and respecting their needs and requirements; communicating effectively with clients and obtaining informed consent; keeping clear and accurate clinical records; and working with the veterinary team to coordinate the care of animals.
Of the proven charges, the Committee determined that his failure to adequately assess Marnie’s health, to obtain a clinical history, to undertake blood tests and recognise that she was seriously ill, amounted to disgraceful conduct in a professional respect and led to “Marnie’s underlying condition going undetected and undoubtedly contributed to her eventual death two days later”.
The Committee also found that Dr Kristin’s decision to hospitalise Marnie without adequate overnight care, place her on IV fluids without monitoring the treatment or her condition, and failure to obtain adequate informed consent – among other things – amounted disgraceful conduct in a professional respect.
Stuart Drummond, chairing the Committee and speaking on its behalf, said: "As a direct result of Dr Kristin’s acts and omissions, Marnie was left alone overnight on fluids when those fluids had nowhere to go. Had he done his job properly he would have known that and Marnie could have avoided the prolonged suffering caused by the chosen course of treatment that did not address the underlying condition. Every element of Dr Kristin’s behaviour was catastrophic for Marnie, and yet he took no personal responsibility for her welfare and just went home.”
Following its findings on disgraceful conduct in a professional respect, the Committee then went on to consider its sanction for both Dr Navarro and Dr Kristin.
In respect of Dr Navarro, the Committee considered the mitigating factors including previous good character, admissions to some of the facts of the case from the outset; genuine insight and remorse into the seriousness of the actions; his youth and inexperience; and relevant and good-quality testimonials from colleagues. The Committee noted that the testimonials were universally positive and demonstrated that Dr Navarro had reflected on his conduct, had become more mature and confident in his practice and made efforts to rectify the areas in which he had fallen below standards.
Stuart Drummond said: “Although the consequences for Marnie and her owners were clearly devastating, the Committee considered that Dr Navarro’s part in her demise has to be seen in the context of all the evidence. In light of the extensive mitigation, including significant evidence of insight and remediation, the Committee was able to conclude that Dr Navarro did not represent a future risk to animals or the public. In such circumstances, the Committee considered that it was not necessary to restrict Dr Navarro’s registration and that a reprimand was the appropriate and proportionate sanction in his case.”
In relation to Dr Kristin, the Committee took into account positive character evidence from Mr Karel Daniel, a semi-retired veterinary surgeon and Vice-President of the Czech Republic Veterinary Chamber, a similar body to the RCVS in that country, as well as other testimonials on his behalf. In mitigation, the Committee considered Dr Kristin’s previously unblemished career, the fact that it was a single case involving a single animal; some development of insight into his conduct; no evidence of repetition; expressions of remorse; the impact of a family bereavement during the course of proceedings; and his financial position.
However, the Committee also took into account aggravating factors including a lack of candour from Dr Kristin when he was giving evidence, demonstrated by a tendency to blame others rather than take responsibility, as well as his recklessness in suggesting a third operation on Marnie that was not in her interests, rather than referring her into specialist care.
The final decision of the Committee on the sanction for Dr Kristin was that, given the seriousness of the misconduct, it was satisfied that this warranted a six-month suspension period. However, given the mitigating factors, the Committee decided that four months was appropriate and proportionate.
Commenting on the sanction Stuart Drummond said: “The Committee determined that it was important a clear message be sent that this sort of behaviour is wholly inappropriate and not to be tolerated. It brings discredit upon the respondent and discredit upon the profession and, most importantly, caused harm to Marnie and great distress to her owners.
"The Committee did consider whether to remove Dr Kristin from the Register. However, in light of the mitigation in this case, the fact that this was a single case in an otherwise unblemished career, together with the unlikelihood he would repeat his disgraceful conduct, the Committee decided that, in all the circumstances, to remove him from the Register would be disproportionate.
"The Committee therefore decided to order that the Registrar suspend Dr Kristin’s registration…. The Committee was satisfied that a period of four months was appropriate and proportionate in all the circumstances."
The full facts and findings from the case can be found at www.rcvs.org.uk/disciplinary
Ceva Animal Health has added to its joint care range with the launch of Meloxidyl Oral Suspension for Cats, licensed for the treatment of musculoskeletal disorders and alleviation of post-operative pain.
Meloxidyl Oral Suspension for Cats is available in 15ml bottles containing 0.5mg/ml meloxicam. Each pack contains a tailored maintenance dosing syringe with a 'kg scale' for all sizes of cat. In addition, Meloxidyl's sweet tasting formulation helps to maximise ease of administration.
Meloxidyl Injection complements Ceva Animal Health's joint care range, which also includes Meloxidyl Injection for dogs and cats and Meloxidyl Oral Suspension for dogs.
For further information, please contact your Ceva Animal Health representative or call 01494 781510.
Andrea, who is also an EBVS Specialist in Small Animal Internal Medicine, is joining Paragon after returning from a spell in Australia. The transfer fee was not disclosed.
Andrea graduated from Bristol in 2011 and became a Specialist in 2017. She said: "I'm so pleased to be returning to my beautiful home county of Yorkshire and joining the brilliant team at Paragon.
"Internal medicine will be my key area and my main interests are infectious diseases and post graduate clinical teaching."
Andrea represented England youth at basketball between 2000 and 2002, starring in tournaments in Hungary and Italy, and her passion for sport is still high on her list of priorities.
She added: "Now I’m back home I’m looking to join a triathlon club and will attempt to master the ukulele, which I recently began playing."
Paragon managing director, Ian Monteith, said: "Andrea is the fifth high-calibre specialist addition we’ve made in the past six months which illustrates our dedication to delivering the highest level of care and treatment to our patients."
Noel Fitzpatrick of Channel 4 Supervet fame has been presented with an award by Guinness World Records after performing the world's first double 'bionic' leg implant on a cat.
The procedure, which was carried out on a cat called Oscar in 2009, was also the first time such implants had been placed into a moving joint.
The award was presented to Noel by Craig Glenday, Editor In Chief of Guinness World Records, at the London Pet Show.
Noel said: "The Guinness Book of Records was the first book I ever had, so receiving this award is a real honour! I'm very humbled, you're only as good as your next operation - you only ever think about providing hope to pets and their owners and doing your best. To be able to help them through the toughest times and see pets like Oscar make a full recovery is the most rewarding feeling and I'm thrilled that the work we carry out at Fitzpatrick Referrals has been recognised by Guinness World Records."
The one-day event, called VetQuest, will allow prospective students to spend the day being mentored by a current student whilst getting involved in interactive sessions, such as large animal skills, clinical skills and veterinary public health.
Participants will learn about the opportunities available to those interested in pursuing a veterinary career, have a tour of the school and attend talks on vet admissions and work experience.
Dr Louisa Slingsby, Teaching Fellow and Faculty Admissions and Recruitment Officer at the Bristol Vet School, said: "VetQuest allows those who are interested in a career in the veterinary professions to come along for a day to find out more about the roles of veterinary surgeons and veterinary nurses.
"They will also have the opportunity to learn what to think about when choosing and applying for courses and how to give themselves the best possible chance to make an informed decision about if vet medicine is the career for them."
There will also be an optional session for parents and carers to help them navigate the challenges of applying to study to be a vet or vet nurse. The morning starts with a tour and then a talk and a Q&A session and finishes around lunchtime.
The cost of the one-day event is £50 and there are a limited number of subsidised places at £10. Lunch is included in the registration fee. To book visit https://www.bristol.ac.uk/vetscience/events/2018/vetquest-2018.html.
The event is primarily aimed at years 11 and 12, although anyone is welcome to attend.
For further information about VetQuest, email: svs-vetquest@bristol.ac.uk or tel: +44 (0)117 928 9280.
The companies are encouraging the use of CT to direct early, targeted surgical intervention and improve outcomes.
Dr Dean Felkler, Founder and CEO of Exotic Vet Support and senior clinician at Tai Wai Small Animal and Exotic Hospital in Hong Kong, says a recent case of his highlights the importance of accurate and early diagnosis.
A 7yr old rabbit was presented for anorexia and hadn’t passed faeces for over 12hrs.
Dean said: “A full diagnostic investigation was performed.
"From the radiographs it is difficult to appreciate the GDV.
"However, on the CT scan, reported by VetCT, it was very obvious when compared to the normal stomach orientation.”
After initial stabilisation the patient underwent surgery to re-orientate the stomach and an incisional gastropexy was performed.
Following surgery the rabbit recovered well and was eating and passing faeces within 24 hours.
Dr David Reese, Director of VetCT Australia and exotics expert said: “We are able to identify several life-threatening pathologies much more accurately with CT than radiographs.
"This is vital for early correction of acute surgical abdominal conditions to increase the likelihood of a positive outcome.”
VetCT is offering a free trial of its specialist teleradiology and teleconsulting services at: www.vet-ct.com
Photo: VetCT report of a CT scan showing GDV in a rabbit - The pylorus (lime green star) denoted by the thick pyloric wall is located on the left side of the abdomen and the fundus (dark pink star) is right laterally located.
Miss Johnson was convicted at North Somerset Magistrates’ Court following a guilty plea of the offence of theft by employee in December 2023, after she stole buprenorphine belonging to Yatton Vets earlier that year.
She was sentenced to a fine of £120, a surcharge of £48, and costs of £85.
There were four further charges against Miss Johnson.
Charge one related to Miss Johnson stealing 5ml of methadone in December 2022 from her employer, Vets4Pets in Bristol, and injecting herself with the methadone.
The police investigated the incident and Miss Johnson accepted a conditional caution for the theft, the condition being she should attend a drug awareness course.
Charge two related to Miss Johnson dishonestly taking a syringe of methadone in August 2023 from her employer, the Langford Small Animal Hospital, and injecting herself with it.
Charge three related to two dates in September 2023 when she dishonestly took methadone, gabapentin and buprenorphine from Yatton Vets, her then employer, injecting herself with the buprenorphine and then working when unfit to do so.
Miss Johnson was later convicted of theft in relation to the buprenorphine (charge five).
Charge four related to an incident in November 2023, when Miss Johnson dishonestly took a syringe of buprenorphine from Bristol PDSA, for the purposes of self-administration, and was dishonest both to other members of staff and in the clinical records about the circumstances of taking the buprenorphine.
Charge five was in relation to Miss Johnson’s criminal conviction.
At the outset of the hearing, Miss Johnson admitted all charges in their entirety.
Having reviewed all the evidence and taken Miss Johnson’s admissions into account, the Committee found each of the charges proved.
After the criminal proceedings had finished and had been reported to the College, Miss Johnson wrote a letter expressing her deepest apologies to both the RCVS and the profession.
Within this she also made it clear that she took full responsibility for her actions.
In a later statement, she added that she had tried to use the experience to learn and improve in every aspect of her career and life and did not want to defend her behaviour.
Within this statement she also retracted a previous request to resign from the register, stating that she would accept any outcome to the investigation.
In deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account:
The Committee identified no mitigating factors and concluded that for each of the individual charges Miss Johnson’s conduct fell far short of the conduct expected of a member of the profession and that each of the charges one to four amounted to serious professional misconduct.
In relation to charge five, the criminal conviction, the Committee noted that the nature and the circumstances of the offence involved dishonesty, abuse of her professional position regarding access to controlled drugs, breach of her employer’s trust, and that the misconduct took place notwithstanding an investigation by the police for similar conduct in December 2022.
The Committee therefore concluded that charge five rendered Miss Johnson unfit to practise.
When deciding on a sanction, the Committee took into account mitigating factors, which included:
The Committee found no further aggravating factors at this stage.
Kathryn Peaty, chairing the Committee and speaking on its behalf said: “The Committee considered that the overall misconduct proved so serious and was incompatible with remaining on the register.”
She added: “The Committee accepted that Miss Johnson was currently likely to be drug-free on the basis of her evidence and that of her referee, but it noted that independent testing proving she had been drug free for any period of time was not available to it.
"Furthermore, Miss Johnson had been unable to demonstrate that she had worked without any incident recently as she had accepted she had been dismissed from her recent job.
“Having taken into account all of the aggravating and mitigating factors, and balancing the public interest and the need to uphold and maintain standards within the profession, and having decided that Miss Johnson’s insight was limited, the Committee concluded that the sanction of ‘removal’ was the only proportionate sanction it could impose in this case.
"It also decided that such a sanction maintained public confidence in the veterinary profession, safeguarded animal welfare and protected the public from any future risk of repetition of similar behaviour.
“The Committee therefore directed that the Registrar remove Miss Johnson’s name from the register of veterinary nurses forthwith.”
1,300 veterinary surgeons responded to the BVA survey, which was carried out in July. They were asked what Official Controls Qualification (OCQ) they hold or have held in the past, and give reasons for dropping a previously held qualification or choosing not to revalidate.
According to the BVA, many respondents criticised the current training and revalidation process, which is administered by Improve International on behalf of the Animal and Plant Health Agency (APHA).
Factors including time, the cumulative cost of renewing each module at regular intervals, a lack of relevance and duplication of learning across different modules were all cited as reasons for choosing to drop qualifications.
25% of vets who currently hold the Essential Skills OCQ say they are planning not to renew the qualification, with 67% saying it is because of the expiry of grandfather rights and 66% saying it is because they find the requirements too onerous.
18% of those who currently hold the Tuberculin Testing OCQ are not planning on renewing, either because they are finding the revalidation requirements too onerous (58%), too expensive (42%) or because the work is not sufficiently rewarding (42%).
35% of those who hold the Statutory Surveillance OCQ are not planning on renewing, primarily because of overly onerous revalidation requirements.
The largest drop off is predicted amongst holders of the Exports OCQ, 38.4% of whom said they plan not to revalidate.
Amongst the species bolt-ons, 45.5% of the holders of the Small Animal Exports OCQ, 51% of the Ungulate Exports OCQ, 66% of the Equine Exports OCQ, 72.5% of the Avian Exports OCQ, 47% of the Product Exports OCQ, 68% of the Germinal Products Exports OCQ and 32% of the Companion Animals OCQ said they plan not to renew, either because of the expiry of grandfather rights, or the expense or, in the case of Ungulate Exports, because revalidation is too onerous.
In the current system equine exports are included in the ungulate export OCQ, which the BVA says was a concern for those vets who only work with farm animals. APHA and Improve International have helpfully introduced an equine-only OCQ for exports that better meets the needs of equine-only vets.
BVA reports that it has had a positive meeting with APHA to discuss the survey results and explore practical solutions to iron out issues with the current system and make it easier to use. As a next step, BVA has agreed to review the modules and make recommendations for improving the structure of training and the revalidation process.
BVA President John Fishwick said: "The unprecedented response rate to this survey really hits home the strength of feeling on this issue. There is an urgent need to review and improve the revalidation process to safeguard against capacity and capability issues in this critical section of the workforce.
"It’s really positive that APHA recognises that there are issues with the current system and is keen to work with us to make it more proportionate and fit for purpose while continuing to maintain high standards. It’s more important than ever to retain skilled professionals so that the workforce is at full strength to respond robustly to disease outbreaks and meet demand for export certification after Brexit."
Andrew Soldan, APHA Veterinary Director said: "The integrity of our official controls and export certification is vitally important. The Official Controls Qualifications are a key part of this as they provide standardised OV training as well as assurance of high standards. I’m grateful to BVA for their assistance as we look to make further improvements to the system in the future."